Medacta Group Financials
| MOVE Stock | 110.60 0.20 0.18% |
Medacta |
Please note, the imprecision that can be found in Medacta Group's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medacta Group SA. Check Medacta Group's Beneish M Score to see the likelihood of Medacta Group's management manipulating its earnings.
| Foreign Associate | USA |
| Instrument | Switzerland Stock View All |
| Exchange | SIX Swiss Exchange |
| ISIN | CH0468525222 |
| Business Address | Strada Regina, 34, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.medacta.com |
| Phone | 41 91 696 60 60 |
You should never invest in Medacta Group without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Medacta Stock, because this is throwing your money away. Analyzing the key information contained in Medacta Group's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Medacta Group Key Financial Ratios
There are many critical financial ratios that Medacta Group's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medacta Group SA reports annually and quarterly.| Return On Equity | 0.21 | |||
| Return On Asset | 0.0752 | |||
| Target Price | 109.63 | |||
| Beta | 1.12 | |||
| Z Score | 19.2 |
Medacta Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medacta Group's current stock value. Our valuation model uses many indicators to compare Medacta Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medacta Group competition to find correlations between indicators driving Medacta Group's intrinsic value. More Info.Medacta Group SA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.35 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medacta Group SA is roughly 2.84 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medacta Group's earnings, one of the primary drivers of an investment's value.Medacta Group SA Systematic Risk
Medacta Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medacta Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Medacta Group SA correlated with the market. If Beta is less than 0 Medacta Group generally moves in the opposite direction as compared to the market. If Medacta Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medacta Group SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medacta Group is generally in the same direction as the market. If Beta > 1 Medacta Group moves generally in the same direction as, but more than the movement of the benchmark.
Medacta Group December 15, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medacta Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medacta Group SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medacta Group SA based on widely used predictive technical indicators. In general, we focus on analyzing Medacta Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medacta Group's daily price indicators and compare them against related drivers.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 7.26 | |||
| Value At Risk | (2.89) | |||
| Potential Upside | 2.32 |
Additional Tools for Medacta Stock Analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.